Nexura Premier

Technical Documentation

Technical documentation covering product identity, system architecture, formulation specifications, commercial information, and documented evidence status for Nexura Premier products.

01

Product Identity

Product
VMAXA
SKU
VMAXA-001
Category
Male Vitality Wellness System
Architecture
Three-phase liquid and tablet system
02

System Architecture

Phase A
VITAL — 50 ml liquid
Phase B
FLOW — 180 tablets total
Phase C
FORCE — 50 ml liquid

VMAXA is documented as a three-phase system comprising VITAL, FLOW, and FORCE. The formulation data below represents the currently documented product composition supplied by Nexura Premier.

03

VITAL — Phase A

VITAL
Pure Libido + Confidence Axis
50 ml total
IngredientPotencyQuantity
DamianaQ12 ml
Nuphar LuteaQ7 ml
Argentum Nit6X9 ml
CaladiumQ9 ml
Avena SativaQ10 ml
Kali Mur6X3 ml
Documented Total
50 ml
Declared Formulation Design Intent
Described by the product formulation as a libido and confidence-oriented phase.
04

FLOW — Phase B

FLOW
Nerve + Endocrine Core
180 tablets total
IngredientPotency
Orchitinum3X
Testis3X
Kali Phos6X
Lycopodium30C
Acid Phos30C
China30C
Selenium30C
Physical Tablet Mapping

FLOW contains 180 tablets in total, documented as 60 larger tablets and 120 smaller tablets. The individual ingredient attribution between the larger and smaller tablet groups is not currently documented.

Documented Components
7 documented constituents
Physical Mapping Status
60 larger / 120 smaller tablet mapping not currently documented
05

FORCE — Phase C

FORCE
Organ + Stamina + Clearance
50 ml total
IngredientPotencyQuantity
Sabal SerrulataQ12 ml
GinsengQ10 ml
Agnus CastusQ10 ml
AshwagandhaQ10 ml
Chelidonium6X5 ml
Zincum6X3 ml
Documented Total
50 ml
Declared Formulation Design Intent
Described by the product formulation as an organ, stamina, and clearance-oriented phase.
06

Commercial Specifications

Founder Special Price
PKR 6,990
Single Box
20-day system
Complete Course
3-month system course
Fulfillment
Nationwide Cash on Delivery (COD)
Estimated Delivery
Approximately 2–4 working days
07

Evidence & Documentation Status

Product Facts

Product identity, phase structure, documented ingredients, potencies, liquid quantities for VITAL and FORCE, and total tablet count for FLOW are documented product specifications.

Classical / Homeopathic Context

Traditional or classical context relating to individual constituents should not be interpreted as evidence of clinical efficacy for the VMAXA formulation itself.

Clinical Evidence Status

No verified clinical efficacy dataset for the VMAXA formulation is currently documented here.

Expert Documentation

No independently verified expert or doctor statement is currently documented on this page.

Customer Outcome Data

No verified aggregate customer-outcome dataset is currently documented on this page.

08

Documentation Boundaries

This page records documented product and formulation information. It does not establish clinical efficacy, guarantee outcomes, or replace individualized professional advice. Specific safety, contraindication, toxicological, and administration documentation should only be added when formally verified.